Evidence map›Paper›PMID 16780580›Full record

ArticleBMC bioinformatics2006

Taking U out, with two nucleases?

I Saira Mian, Elizabeth A Worthey, Reza Salavati

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

I Saira MianLife Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720-8265, USA. SMian@lbl.gov
Elizabeth A Worthey
Reza Salavati
Lawrence Berkeley National Laboratory · USMcGill University · CA

Funding

Comparative Analysis of Editosome in TrypanosomatidsR21AI053784 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI SALAVATI, REZA SALAVATI · 2002 to 2003
$537k
NIAID NIH HHS 1R21AI053784-0NIAID NIH HHS R21 AI053784
6 · The paper itself

Abstract

backgroundREX1 and REX2 are protein components of the RNA editing complex (the editosome) and function as exouridylylases. The exact roles of REX1 and REX2 in the editosome are unclear and the consequences of the presence of two related proteins are not fully understood. Here, a variety of computational studies were performed to enhance understanding of the structure and function of REX proteins in Trypanosoma and Leishmania species.

resultsSequence analysis and homology modeling of the Endonuclease/Exonuclease/Phosphatase (EEP) domain at the C-terminus of REX1 and REX2 highlights a common active site shared by all EEP domains. Phylogenetic analysis indicates that REX proteins contain a distinct subfamily of EEP domains. Inspection of three-dimensional models of the EEP domain in Trypanosoma brucei REX1 and REX2, and Leishmania major REX1 suggests variations of previously characterized key residues likely to be important in catalysis and determining substrate specificity.

conclusionWe have identified features of the REX EEP domain that distinguish it from other family members and hence subfamily specific determinants of catalysis and substrate binding. The results provide specific guidance for experimental investigations about the role(s) of REX proteins in RNA editing.

Indexed as

Models, BiologicalModels, ChemicalBinding SitesComputer SimulationModels, MolecularProtein BindingProtein ConformationRNA EditingSequence Analysis, ProteinUDPglucose-Hexose-1-Phosphate UridylyltransferaseUDPglucose-Hexose-1-Phosphate Uridylyltransferase

Identifiers

PMID16780580
PMCPMC1525001
OpenAlexW1691146018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.